Silverfin false false 31/03/2024 31/03/2024 01/04/2023 no description of principal activity Dr Marcus Rauch 05/03/2018 Dr Angelique Van 'T Wout 29/07/2018 Dr Robert Anthony Williamson 05/03/2018 11232306 2024-03-31 11232306 bus:Director1 2024-03-31 11232306 bus:Director2 2024-03-31 11232306 bus:Director3 2024-03-31 11232306 2023-03-31 11232306 core:CurrentFinancialInstruments 2024-03-31 11232306 core:CurrentFinancialInstruments 2023-03-31 11232306 2023-04-01 2024-03-31 11232306 bus:Micro-entities 2023-04-01 2024-03-31 11232306 bus:AbridgedAccounts 2023-04-01 2024-03-31 11232306 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11232306 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11232306 bus:Director1 2023-04-01 2024-03-31 11232306 bus:Director2 2023-04-01 2024-03-31 11232306 bus:Director3 2023-04-01 2024-03-31 11232306 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure

Company No: 11232306 (England and Wales)

ALPHABIOMICS LTD

Abridged Unaudited Financial Statements
For the financial year ended 31 March 2024

ALPHABIOMICS LTD

ABRIDGED UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 March 2024

Contents

ALPHABIOMICS LTD

COMPANY INFORMATION

For the financial year ended 31 March 2024
ALPHABIOMICS LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2024
DIRECTORS Dr Marcus Rauch
Dr Angelique Van 'T Wout
Dr Robert Anthony Williamson
REGISTERED OFFICE 4 Queensway
Ponteland
Newcastle Upon Tyne
NE20 9RZ
England
United Kingdom
COMPANY NUMBER 11232306 (England and Wales)
ACCOUNTANT Synergee
Pluto House
6 Vale Avenue
Tunbridge Wells
TN1 1DJ
ALPHABIOMICS LTD

BALANCE SHEET

As at 31 March 2024
ALPHABIOMICS LTD

BALANCE SHEET (continued)

For the financial year ended 31 March 2024
2024 2023
£ £
Fixed assets 2,123 967
Current assets 32,918 333,485
Prepayments and accrued income 291 1,673
Creditors: amounts falling due within one year ( 13,552) ( 18,976)
Net current assets 19,657 316,182
Total assets less current liabilities 21,780 317,149
Accruals and deferred income ( 22,051) ( 316,850)
Net (liabilities)/assets ( 271) 299
Capital and reserves ( 271) 299

For the financial year ending 31 March 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of AlphaBiomics Ltd (registered number: 11232306) were approved and authorised for issue by the Board of Directors on 04 October 2024 and were signed on its behalf by:

Dr Marcus Rauch
Director
Dr Angelique Van 'T Wout
Director
Dr Robert Anthony Williamson
Director
ALPHABIOMICS LTD

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

For the financial year ended 31 March 2024
ALPHABIOMICS LTD

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 March 2024

1. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors - -